Ascentage Pharma Group International (AAPG)

AAPG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,594	1,812	995	851	932	1,096
Market Cap Growth	66.45%	82.10%	16.89%	-8.64%	-15.02%	39.78%
Enterprise Value	2,604	1,896	1,009	830	798	1,045
PS Ratio	47.58	13.48	31.78	27.99	212.05	574.86
PB Ratio	27.50	48.23	99.87	14.36	4.79	8.45
P/TBV Ratio	32.59	80.87	-	19.59	5.15	9.47
EV/Sales Ratio	47.75	14.11	32.24	27.31	181.70	548.17
Debt / Equity Ratio	2.54	6.09	25.42	4.39	0.88	0.63
Asset Turnover	0.13	0.38	0.08	0.07	0.01	0.01
Inventory Turnover	3.70	2.56	2.38	3.29	-	-
Quick Ratio	1.40	1.17	1.35	1.78	5.05	3.77
Current Ratio	1.54	1.26	1.44	1.86	5.22	3.91
Return on Equity (ROE)	-159.65%	-235.32%	-386.28%	-107.45%	-75.18%	-78.02%
Return on Assets (ROA)	-22.77%	-9.25%	-20.92%	-19.14%	-24.97%	-29.14%
Return on Capital (ROIC)	-28.78%	-12.43%	-27.41%	-24.43%	-31.57%	-36.13%
Return on Capital Employed (ROCE)	-62.00%	-26.10%	-57.00%	-45.30%	-36.20%	-47.00%
Earnings Yield	-6.24%	-3.07%	-13.12%	-15.04%	-13.22%	-9.47%
FCF Yield	-1.20%	-1.03%	-10.95%	-14.60%	-17.57%	-12.02%
Buyback Yield / Dilution	-12.40%	-7.00%	-7.07%	-3.56%	-17.93%	-84.97%

Updated Sep 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q